← All patents

US20220143159A1

Cystatin C and Cystatin 9 to Treat Inflammation Caused by Bacteria

University of Texas System

Abstract

The present invention includes a composition and method for controlling an immune response in a host to a pathogenic bacterial infection comprising: identifying a subject in need of treatment for infection with a pathogenic bacteria; and providing a composition comprising recombinant Cystatin 9 ( …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Tonyia Eaves-Pyles
Priority date
November 30, 2016
Filing date
December 14, 2021
Publication date
May 12, 2022
Language
en
Metadata fetched
August 29, 2026 00:30